Thienopyridines, a safety net with holes in it

Catheterization and Cardiovascular Interventions

Volumn 59, Issue 3, 2003, Pages 303-304

  Wenaweser, Peter ^a   Hess, Otto M ^a   Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; ERYTHROMYCIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENO[2,3 B]PYRIDINE DERIVATIVE; TICLOPIDINE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; INTERMETHOD COMPARISON; NOTE; RISK FACTOR; SIDE EFFECT; STENT; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG RESISTANCE; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STENTS; TREATMENT OUTCOME;

EID: 0037678478     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10585     Document Type: Note

References (6)

1. Eikelboom JW, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002;105:1650-1655.
2. Barrera CF, et al. Baseline platelet function in "low responders" to antiplatelet treatment following coronary stent implantation. Abstract 2556 75th American Heart Association Meeting, Chicago Illinois, USA; November 17-20, 2002.
3. Gawaz M, et al. Comparison of effects of clopiodgrel versus ticlopidine on platelet function in patients function in patients undergoing coronary stent placement. Am J Cardiol 2001;87:332-336.
4. Wenaweser P, et al. The phenomenon of late stent thrombosis: differential effect of ticlopidine and clopidogrel. Abstract 2554 75th American Heart Association Meeting, Chicago Illinois, USA; November 17-20, 2002.
5. Bhatt D, et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002;39:9-14.
6. Wei C, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 2003;107:32-37.